Chronic Rhinosinusitis Trial, Recruiting NCT06986629 Sponsor: Cairo University Condition: Chronic Rhinosinusitis
Back to Chronic Rhinosinusitis

Chronic Rhinosinusitis Trial, Recruiting

NCT06986629
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You have mild to moderate nasal allergy symptoms, with a symptom score of 9 or below on a standard scale
  • You are between 20 and 40 years old
  • Both men and women can apply
  • You have had a positive allergy test (either a skin prick test or a blood allergy test) in the last 12 months showing you are allergic to common year-round allergens such as dust mites, mold, insects, or animal dander (e.g., pet fur or skin flakes)

Who may not be able to join:

  • Women who are pregnant or breastfeeding
  • People who have a significantly crooked nasal septum (the wall inside your nose), or who have had any surgery in the last 6 months
  • People who have high blood pressure, diabetes, any type of cancer, active tuberculosis, asthma, or other serious ongoing health conditions
  • People who regularly use steroid medications or medications that suppress the immune system
  • People who have taken part in another clinical trial within the last 30 days
  • People who have an overactive thyroid gland
  • People who have recently used certain medications, including antihistamines, steroid sprays or tablets, nasal decongestants, antidepressants, or anti-inflammatory painkillers — the exact time limits vary per medication (confirm with trial site)
  • People who have tattoos, moles, or darker skin tone (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +201156644369

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
1 February 2025
Est. completion
1 July 2025

Where this trial is recruiting

🇪🇬 Egypt

Primary endpoints

assessment of change of quality of life

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov